Spin-out raises £1.25m for ‘human gut’ alternative to animal testing
A biotech company that has created a model of a human gut to trial new drugs and foodstuffs without the use of animals has raised £1.25m from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures. Aelius Biotech, a spin out from Newcastle University, provides testing services